Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data

• Main Authors: Janos Revesz (Author), Boglarka Posfai (Author), Laszlo Pajor (Author), Timea Papdan (Author), Linda Varga (Author), Viktor R. Paczona (Author), Zoltan Varga (Author), Farkas Sukosd (Author), Aniko Maraz (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Programmed cell death (PD)-1/PD-ligand 1 (PD-L1) inhibitors have made a breakthrough in the therapy of advanced urothelial bladder cancer (UBC). The impact of Fibroblast Growth Factor Receptor 3 (FGFR3) mutation on the effectiveness of PD-L1 treatment remains still unclear. Objective: Ou...